Viewing Study NCT02741557

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 6:31 PM

Ignite Modification Date: 2025-12-25 @ 4:01 PM

Study NCT ID: NCT02741557

Status: COMPLETED

Last Update Posted: 2019-07-15

First Post: 2016-04-14

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Bioequivalence Study of a Fixed-dose Combination (FDC) of Dolutegravir (DTG) and Rilpivirine (RPV)

Sponsor: ViiV Healthcare

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module